CN103278648B - 一种白蛋白检测试剂 - Google Patents
一种白蛋白检测试剂 Download PDFInfo
- Publication number
- CN103278648B CN103278648B CN201310200471.2A CN201310200471A CN103278648B CN 103278648 B CN103278648 B CN 103278648B CN 201310200471 A CN201310200471 A CN 201310200471A CN 103278648 B CN103278648 B CN 103278648B
- Authority
- CN
- China
- Prior art keywords
- dilution
- reagent
- albumin
- measuring reagent
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 58
- 108010088751 Albumins Proteins 0.000 title claims abstract description 33
- 102000009027 Albumins Human genes 0.000 title claims abstract description 33
- 238000001514 detection method Methods 0.000 title abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims abstract description 31
- 239000004094 surface-active agent Substances 0.000 claims abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 8
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 6
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 6
- 239000000872 buffer Substances 0.000 claims abstract description 6
- 238000004108 freeze drying Methods 0.000 claims abstract description 6
- -1 trihydroxymethyl amino Chemical group 0.000 claims abstract description 6
- 238000010790 dilution Methods 0.000 claims description 27
- 239000012895 dilution Substances 0.000 claims description 26
- 239000012530 fluid Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 238000013016 damping Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 9
- 239000007983 Tris buffer Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 7
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical class COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 6
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 claims description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 230000002452 interceptive effect Effects 0.000 claims description 5
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 229920000151 polyglycol Polymers 0.000 claims description 4
- 239000010695 polyglycol Substances 0.000 claims description 4
- 229920000136 polysorbate Polymers 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 4
- 108010015428 Bilirubin oxidase Proteins 0.000 claims description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 3
- 239000000276 potassium ferrocyanide Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000008362 succinate buffer Substances 0.000 claims description 3
- 150000005846 sugar alcohols Polymers 0.000 claims description 3
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 claims description 3
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 claims description 2
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 125000000647 trehalose group Chemical group 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 2
- 229930003268 Vitamin C Natural products 0.000 abstract description 2
- 235000019154 vitamin C Nutrition 0.000 abstract description 2
- 239000011718 vitamin C Substances 0.000 abstract description 2
- 239000003085 diluting agent Substances 0.000 abstract 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000003223 protective agent Substances 0.000 abstract 1
- 238000012123 point-of-care testing Methods 0.000 description 19
- 238000005516 engineering process Methods 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229940101027 polysorbate 40 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310200471.2A CN103278648B (zh) | 2013-05-24 | 2013-05-24 | 一种白蛋白检测试剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310200471.2A CN103278648B (zh) | 2013-05-24 | 2013-05-24 | 一种白蛋白检测试剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103278648A CN103278648A (zh) | 2013-09-04 |
CN103278648B true CN103278648B (zh) | 2015-01-21 |
Family
ID=49061225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310200471.2A Expired - Fee Related CN103278648B (zh) | 2013-05-24 | 2013-05-24 | 一种白蛋白检测试剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103278648B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102205101B1 (ko) * | 2014-02-28 | 2021-01-19 | 닛토덴코 가부시키가이샤 | 소변 검사 장치 및 정량적 소변 검사를 위한 건식 시약 |
CN104316694B (zh) * | 2014-08-22 | 2016-09-07 | 山东博科生物产业有限公司 | 一种灵敏度高的肌钙蛋白i检测试剂 |
CN106908612B (zh) * | 2015-12-22 | 2019-04-30 | 山东博科生物产业有限公司 | 一种抗肝素稳定的白蛋白检测试剂盒 |
CN106525829A (zh) * | 2016-10-31 | 2017-03-22 | 百奥森(江苏)食品安全科技有限公司 | 一种蛋白质快速检测试纸及其制备方法 |
CN107064527A (zh) * | 2017-04-12 | 2017-08-18 | 济南协谦医疗器械有限公司 | 一种血清白蛋白检测试剂盒 |
CN109916893A (zh) * | 2019-04-12 | 2019-06-21 | 吉林省汇酉生物技术股份有限公司 | 一种定量检测白蛋白含量的干化学试剂片及其制备方法 |
KR102268024B1 (ko) * | 2019-09-30 | 2021-06-23 | 주식회사 청도제약 | 높은 민감도를 가진 소변 내 미세알부민 검출 시험 스트립 |
CN112362878A (zh) * | 2020-11-03 | 2021-02-12 | 吉林省富生医疗器械有限公司 | 一种微量白蛋白检测冻干试剂及预存有冻干试剂的反应管 |
CN112858690B (zh) * | 2021-01-21 | 2023-11-10 | 宁波职业技术学院 | 一种尿白蛋白/尿肌酐复合质控品及其制备方法 |
CN113092781B (zh) * | 2021-03-31 | 2023-01-31 | 深圳市锦瑞生物科技有限公司 | 一种白蛋白测定试剂球的制备方法、试剂球及微流控芯片 |
CN114011480B (zh) * | 2021-11-04 | 2023-04-07 | 上海速创诊断产品有限公司 | 一种电化学发光微流控检测芯片及用于蛋白检测的试剂盒 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056750A (zh) * | 1991-07-15 | 1991-12-04 | 中国人民解放军302医院 | 一种测定血清白蛋白用的试剂及其制备方法 |
CN101221183A (zh) * | 2007-01-12 | 2008-07-16 | 广东省药品检验所 | 一种鉴别人血白蛋白制品的方法 |
CN102417922A (zh) * | 2010-09-25 | 2012-04-18 | 浙江世纪康大医疗科技有限公司 | 一种消除抗坏血酸干扰的尿酸酶法测定试剂及其使用方法 |
CN102417921A (zh) * | 2010-09-25 | 2012-04-18 | 浙江世纪康大医疗科技有限公司 | 一种抗胆红素干扰的尿酸酶法测定试剂及其使用方法 |
CN102435749A (zh) * | 2011-09-02 | 2012-05-02 | 宁波美康生物科技股份有限公司 | 用循环酶法测定β-羟丁酸的液体稳定试剂盒 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4330296A (en) * | 1980-06-23 | 1982-05-18 | Beckman Instruments, Inc. | Albumin reagent and assay |
KR100318552B1 (ko) * | 1998-12-24 | 2002-09-05 | 한국과학기술연구원 | 간질환관련표식물질의검출용스트립 |
-
2013
- 2013-05-24 CN CN201310200471.2A patent/CN103278648B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056750A (zh) * | 1991-07-15 | 1991-12-04 | 中国人民解放军302医院 | 一种测定血清白蛋白用的试剂及其制备方法 |
CN101221183A (zh) * | 2007-01-12 | 2008-07-16 | 广东省药品检验所 | 一种鉴别人血白蛋白制品的方法 |
CN102417922A (zh) * | 2010-09-25 | 2012-04-18 | 浙江世纪康大医疗科技有限公司 | 一种消除抗坏血酸干扰的尿酸酶法测定试剂及其使用方法 |
CN102417921A (zh) * | 2010-09-25 | 2012-04-18 | 浙江世纪康大医疗科技有限公司 | 一种抗胆红素干扰的尿酸酶法测定试剂及其使用方法 |
CN102435749A (zh) * | 2011-09-02 | 2012-05-02 | 宁波美康生物科技股份有限公司 | 用循环酶法测定β-羟丁酸的液体稳定试剂盒 |
Non-Patent Citations (5)
Title |
---|
IMPROVED AND MORE SPECIFIC BROMCRESOL GREEN METHODS FOR THE MANNUL AND AUTOMATIC DETERMINATION OF SERUM ALBUMIN;STEEN INGWERSEN et al;《Clinica Chimica Acta》;19781231;第88卷;545-550 * |
SERUM ALBUMIN ESTIMATION: MODIFICATION OF THE BROJICRESOL GREEN METHOD;I. G.McLPHERSON et al;《 Clin. Chim Acta》;19721231;第37卷;117-121 * |
双试剂溴甲酚绿法测定清蛋白的临床评价;蒋兴亮等;《重庆医学》;20090228;第38卷(第4期);摘要,1.2节,3讨论 * |
溴甲酚绿法测定血清白蛋白配方的正交实验及方法学评价;李树华等;《现代预防医学》;20081231;第35卷(第7期);1326-1327 * |
血清白蛋白测定(BCG法)试剂盒中BCG、Brij-35浓度及工作液pH值对测定结果的影响;赵海舰等;《陕西医学检验》;19990228;第14卷(第1期);9-11 * |
Also Published As
Publication number | Publication date |
---|---|
CN103278648A (zh) | 2013-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103278648B (zh) | 一种白蛋白检测试剂 | |
CN103276052B (zh) | 一种尿素氮检测试剂 | |
CN103278468B (zh) | 一种肌酐检测试剂 | |
CN103278469B (zh) | 一种总蛋白检测试剂 | |
CN103266166B (zh) | 一种葡萄糖检测试剂 | |
CN103320498B (zh) | 一种天冬氨酸氨基转移酶检测试剂 | |
US11808777B2 (en) | Method of analyzing diluted biological sample component | |
CN103278652B (zh) | 一种总胆红素检测试剂 | |
CN103320497B (zh) | 一种丙氨酸氨基转移酶检测试剂 | |
Schnabl et al. | Evaluation of the analytical performance of the Nova StatSensor creatinine meter and reagent strip technology for whole blood testing | |
JP5139538B2 (ja) | 電位差式センサチップ、電位差測定方法、及び測定キット | |
CN104673879A (zh) | 一种小而密低密度脂蛋白胆固醇检测试剂盒及其制备 | |
CN103276051B (zh) | 一种碱性磷酸酶检测试剂 | |
CN103266165B (zh) | 一种淀粉酶检测试剂 | |
CN107884401A (zh) | 消除脂血干扰的葡萄糖氧化酶测定方法 | |
CN103266164B (zh) | 一种亮氨酸氨基肽酶检测试剂 | |
CN102041296A (zh) | 一种血清低密度脂蛋白胆固醇(ldl-c)匀相法体外诊断试剂 | |
CN103333945B (zh) | 一种直接胆红素检测试剂 | |
CN104673880A (zh) | 一种小而密低密度脂蛋白胆固醇检测试方法 | |
CN104678107A (zh) | 一种游离脂肪酸的定量测定方法、试剂及试剂盒 | |
CN106404686A (zh) | 一种抗肝素的血清总胆红素(钒酸盐氧化法)检测试剂盒 | |
CN108949902A (zh) | 一种血清小而密低密度脂蛋白胆固醇检测试剂盒 | |
CN105203533A (zh) | 一种分析灵敏度高的N-乙酰-β-D-氨基葡萄糖苷酶检测试剂 | |
CN103290097B (zh) | 一种γ-谷氨酰基转移酶检测试剂 | |
Fraser et al. | Better laboratory evaluations of instruments and kits are required. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zou Bingde Inventor after: Zou Jihua Inventor after: Zhang Guichun Inventor after: Wo Yanbo Inventor before: Zou Bingde Inventor before: Zou Jihua Inventor before: Zhang Guichun Inventor before: Wo Yanbo Inventor before: Zhou Haibin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZOU BINGDE ZOU JIHUA ZHANG GUICHUN WO YANBO ZHOU HAIBIN TO: ZOU BINGDE ZOU JIHUA ZHANG GUICHUN WO YANBO |
|
ASS | Succession or assignment of patent right |
Owner name: NINGBO MEDICALSYSTEM CLINICAL LABORATORIES CO., LT Free format text: FORMER OWNER: NINGBO MEIKANG BIOTECHNOLOGY CO., LTD. Effective date: 20141215 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20141215 Address after: 315104 Zhejiang city of Ningbo province Yinzhou District Qiming Road No. 269 Applicant after: Ningbo Medicalsystem Clinical Laboratories Co., Ltd. Address before: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299 Applicant before: Ningbo Meikang Biotechnology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150121 Termination date: 20150524 |
|
EXPY | Termination of patent right or utility model |